GILD 241213 86.00P (GILD241213P86000) Stock Options, News & Quotes - Moomoo

US OptionsDetailed Quotes

GILD241213P86000

Watchlist

0.11
-0.02-15.38%

15min DelayClose Dec 10 16:00 ET

0.11High0.11Low

Intraday

5D
Daily

News

Express News | Gilead : Leerink Partners Raises Target Price to $99 From $96
Reuters06:29 ET
Gilead Sciences' Strategic Focus on Lenacapavir and Lifecycle Management Drives Buy Rating
TipRanks06:07 ET · Ratings
BofA Securities Initiates Gilead Sciences(GILD.US) With Buy Rating, Announces Target Price $109
Moomoo News03:32 ET · Ratings
BofA Restarts Coverage of 11 Large-cap Biopharmas
Seeking Alpha17:01 ET
Unusual Options Activity: AI, MSTR and Others Attract Market Bets, AI V/OI Ratio Reaches 249.3
Moomoo News16:30 ET
Market Falls Wednesday, but Googles Chip Impresses | WST
Kevin Travers16:19 ET

Comments

$Gilead Sciences (GILD.US)$
low attention stock, just another day!

Share Your Profit/Loss

6

$Gilead Sciences (GILD.US)$ $Merck & Co (MRK.US)$

1

$Gilead Sciences (GILD.US)$

FDA PDUFA Update…

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...

8

Read more